Suppr超能文献

急性冠状动脉综合征患者的他汀类药物治疗:低密度脂蛋白胆固醇目标达标情况及他汀类药物效力的影响。

Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency.

机构信息

Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand ; Clinical Epidemiology Program, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Center of Excellence in Applied Epidemiology, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.

出版信息

Ther Clin Risk Manag. 2015 Jan 23;11:127-36. doi: 10.2147/TCRM.S75608. eCollection 2015.

Abstract

BACKGROUND

Elevated low-density lipoprotein cholesterol (LDL-C) is associated with an increased risk of coronary artery disease. Current guidelines recommend an LDL-C target of <70 mg/dL (<1.8 mmol/L) for acute coronary syndrome (ACS) patients, and the first-line treatment to lower lipids is statin therapy. Despite current guidelines and the efficacious lipid-lowering agents available, about half of patients at very high risk, including ACS patients, fail to achieve their LDL-C goal. This study assessed LDL-C goal attainment according to use of high and low potency statins in routine practice in Thailand.

METHODS

A retrospective cohort study was performed by retrieving data from medical records and the electronic hospital database for a tertiary care hospital in Thailand between 2009 and 2011. Included were ACS patients treated with statins at baseline and with follow-up of LDL-C levels. Patients were divided into high or low potency statin users, and the proportion reaching the LDL-C goal of <70 mg/dL was determined. A Cox proportional hazard model was applied to determine the relationship between statin potency and LDL-C goal attainment. Propensity score adjustment was used to control for confounding by indication.

RESULTS

Of 396 ACS patients (60% males, mean age 64.3±11.6 years), 229 (58%) were treated with high potency statins and 167 (42%) with low potency statins. A quarter reached their target LDL-C goal (25% for patients on high potency statins and 23% on low potency statins). High potency statins were not associated with increased LDL-C goal attainment (adjusted hazards ratio 1.22, 95% confidence interval 0.79-1.88; P=0.363).

CONCLUSION

There was no significant effect of high potency statins on LDL-C goal attainment. Moreover, this study showed low LDL-C goal attainment for patients on either low or high potency statins. The reasons for the low LDL-C goal attainment rate warrants further investigation.

摘要

背景

升高的低密度脂蛋白胆固醇(LDL-C)与冠状动脉疾病的风险增加有关。目前的指南建议急性冠脉综合征(ACS)患者的 LDL-C 目标值<70mg/dL(<1.8mmol/L),降低血脂的一线治疗方法是他汀类药物治疗。尽管有目前的指南和有效的降脂药物可用,但包括 ACS 患者在内的高危患者中,约有一半未能达到 LDL-C 目标。本研究评估了泰国常规实践中使用高、低效他汀类药物治疗时 LDL-C 目标的达标情况。

方法

通过检索泰国一家三级保健医院 2009 年至 2011 年的病历和电子医院数据库,进行回顾性队列研究。纳入的患者为接受他汀类药物治疗且有 LDL-C 水平随访的 ACS 患者。患者分为高或低效他汀类药物使用者,并确定达到 LDL-C 目标值<70mg/dL 的比例。应用 Cox 比例风险模型确定他汀类药物效力与 LDL-C 目标值达标之间的关系。采用倾向评分调整控制混杂因素。

结果

396 例 ACS 患者(60%为男性,平均年龄 64.3±11.6 岁)中,229 例(58%)接受高效力他汀类药物治疗,167 例(42%)接受低效力他汀类药物治疗。四分之一的患者达到了目标 LDL-C 水平(高效力他汀类药物治疗患者为 25%,低效力他汀类药物治疗患者为 23%)。高效力他汀类药物与 LDL-C 目标值达标率的增加无关(调整后的危险比 1.22,95%置信区间 0.79-1.88;P=0.363)。

结论

高效力他汀类药物对 LDL-C 目标值达标没有显著影响。此外,本研究显示,接受低或高效力他汀类药物治疗的患者 LDL-C 目标值达标率较低。需要进一步研究 LDL-C 目标值达标率低的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81d7/4315463/4c7802c44505/tcrm-11-127Fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验